retatrutide safety trial Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA Retatrutide Where to Get: Can

Monitoring for new autoimmune manifestations Although rare, the possibility that GLP-1/GIP receptor agonism could trigger new autoimmune manifestations in susceptible individuals has been raised by case reports

After protein, fat and carbohydrate allocation depends on personal preference, training style, and metabolic response

If you're not accustomed to prebiotic supplements, you might notice temporary bloating or digestive adjustment in the first week or two - that's typical as your gut microbiome adapts, and it generally resolves on its own

Br Med Bull 136:118126

Birth control is probably a little bit more likely [to fail], if you're on something that decreases absorption, says Christina Boots, a reproductive endocrinologist and infertility specialist at Northwestern University in Chicago, Illinois

That distinction matters when youre perimenopausal, working a full-time job, managing a household, and the last thing you want is another weekly check-in with another app telling you to drink more water